Class Actions from Mode

Axsome Therapeutics Securities Settlement: Investors May Claim Cash from $7.75M Fund

If you bought shares of this company during the class period and later saw losses, there’s now a $7.75 million settlement available. This post breaks everything down so you can quickly see whether you qualify, how much you might receive, and how to file before the deadline.

Investors alleged the company and certain executives made false or misleading statements about a drug candidate, regulatory submissions, and manufacturing issues. According to the complaint, these statements inflated the stock price—causing losses when the truth surfaced.

The company denies all wrongdoing but agreed to settle to avoid further litigation.

Who Qualifies?

You’re part of the settlement if you:

  • Purchased or otherwise acquired common stock between May 10, 2021 – April 22, 2022, and
  • Suffered financial losses related to the alleged securities violations.

Both individuals and entities can file claims. Financial institutions or nominees must notify their beneficial owners.

How Much You Can Receive?

Payments come from a $7.75M settlement fund, minus fees and costs.

Your payout depends on:

  • How many valid claims are submitted
  • How many shares you bought or sold
  • Your recognized loss, based on formulas in the court-approved Plan of Allocation

Estimated average recovery per share:

  • ~$0.46 per share before fees
  • ~$0.30 per share after deductions

Claims under $10 will not be paid.

Proof is required. You must submit trade documentation (broker statements, confirmations, etc.).

Your Options (At a Glance)

OptionWhat It MeansDeadline
Submit a Claim FormThe only way to receive a payment.Feb. 3, 2026
Request ExclusionKeep your right to sue separately; receive no payout.Jan. 13, 2026
ObjectTell the Court you disagree with the settlement terms.Jan. 13, 2026
Do NothingReceive no payment and lose rights.No deadline

How to File?

You can submit your claim online or by mail.

You must include:

  • Last four digits of SSN or full TIN
  • Details of each purchase, acquisition, and sale
  • Documentation proving all transactions (confirmation slips, statements, or similar broker records)

Mailing Address:
Axsome Therapeutics Inc. Securities Litigation
c/o Strategic Claims Services
600 N. Jackson St., Ste. 205
P.O. Box 230
Media, PA 19063

Submit Your Claim Here

Related Articles

 

Filing Settlement Claims

Important: If you do not qualify for this settlement, do not submit a claim.
Submitting false or misleading information will result in your claim being rejected and may carry legal consequences for perjury. Dishonest claims also take away from Class Members who are rightfully entitled to settlement benefits.
If you’re unsure about your eligibility, visit the official Settlement Administrator’s website and review their FAQ. (Note: modeclassactionsdaily.com is an informational resource only and is not affiliated with any class action administrator.)Don’t qualify for this one? Browse our database of other open settlements you may be eligible to join.